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Functional dyspepsia (FD) and irritable bowel syndrome (IBS) 
are common gastrointestinal (GI) diseases, comprising 10 to 
25% of the general population.1,2 However, there are several 
reports regarding frequent overlap between FD and IBS pa-
tients.3-5 Recently, a meta-analysis by Ford, et al.1 estimated the 
prevalence of dyspepsia in IBS to be 27%, while the frequency 
of IBS among patients with FD was predicted to be higher than 
37%. According to Rome III criteria, subjects with overlapping 
FD and IBS show a significant increase in the severity of psy-
chopathology, as well as pathophysiological features.6-8 Like-
wise, Tack, et al.9 also found that patients with FD-IBS overlap 
had a greater prevalence of hypersensitivity to gastric distention 
and more severe FD symptoms, compared with patients of FD 
alone. It is speculated that the overlap syndrome may be a ma-
nifestation of generalized GI motor disturbances, altered vis-
ceral sensitivity/or brain-gut dysfunction, and stressful early life 
events.8-13 Studies in rodents have found that stress enhances 
gastric contractions, stimulates colonic transit, and causes vis-
ceral hyperalgesia. These findings demonstrated that stress 
might induce abnormalities in GI function.14-16
Stress is one of the primary factors associated with the onset, 
exacerbation, and reactivation of many GI disorders.10,11 The 
detail mechanisms by which stress leads to disordered GI func-
tions still remain to be discovered. However, strong experi-
mental evidence suggests that corticotropin releasing factor 
(CRF) and its receptors in the brain facilitate stress-related al-
terations in GI motility.12,13,17,18 Central injection of CRF ligands 
in experimental animals reproduces stress related alterations 
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of gut motor function, whereas CRF antagonist administration 
prevents the effects of various stressors.12 In addition to the 
brain, CRF ligands and receptors are widely expressed in en-
teric nervous system neurons and other cells of the GI tract in 
animals and humans.19-22 Remarkably, peripheral administra-
tion of CRF ligands was found to mimic changes similar to that 
induced by stress, while its antagonists alleviate stress-induced 
alteration of GI function.23,24 This indicates the co-existence of 
a peripheral and central CRF signaling pathway, and together, 
they might play critical role in stress-related alterations of gut 
function. Several studies reported differential action of CRF li-
gands upon interaction with different CRF receptor subtypes 
on upper and lower GI motility.25,26
Apart from CRF induced stress, water avoidance stress (WAS) 
is also used as a model to study psychological stress.14-16,27 Enck, 
et al.28 reported that WAS delays gastric emptying, while Nozu, 
et al.16 demonstrated enhanced gastric contractions are medi-
ated by peripheral CRF1 receptors. However, several studies 
have shown that WAS augments lower GI transit.14,15,28 In the 
colon, WAS stimulates motility mediated by the central CRF 
pathway.14,15,28 However, the relationship between stress and 
impairment of GI motor activity has not been fully elucidated. 
Therefore, the aim of the present study was to determine the 
effect of peripheral CRF peptide and water avoidance induced 
stress on the colonic and the gastric transit in the guinea pig 
model.
Adult male Hartley guinea pigs (250–350 g, Orient Bio, Inc., 
Seoul, Korea) were acclimatized to their holding room. A stan-
dard guinea pig diet and drinking water were provided ad libi-
tum. All experiments were conducted in accordance with the 
guidelines of animal laboratory Ethics Committees of the De-
partment of Laboratory Animal Medicine, Medical Research 
Center, Yonsei University College of Medicine. This study was 
approved by the Institutional Animal Care and Use Commit-
tee of Yonsei University College of Medicine with IRB protocol 
number 2015-0221.
The following chemicals and drugs were used: isotonic so-
dium chloride solution (Dai Han Pharmaceuticals, Seoul, Ko-
rea), charcoal (Sigma, Milwaukee, WI, USA), barium sulfate 
(Taejoon Pharmaceuticals, Seoul, Korea), r/h CRF (Peptide In-
stitute, Inc., Osaka, Japan) and Astressin (Sigma, St. Louis, MO, 
USA). 
The effect of CRF treatment on upper GI transit was tested 
by charcoal transit assay in fasted guinea pigs. r/h CRF pep-
tides of different concentrations (1, 3, and 10 μg/kg) and vehi-
cle (saline) were injected intraperitoneal (IP) in guinea pigs. 
CRF receptor blockade by astressin and the effect of CRF on 
the upper GI transit was measured by charcoal transit assay. 
Guinea pigs were IP injected with different doses of astressin 
(1, 3, and 10 μg/kg) and vehicle (saline) and incubated for 15 
minutes. Subsequently, each of these groups was injected with 
10 μg/kg of IP CRF. After 30 minutes of stabilization, 3 mL of 
charcoal mixture was administered via orogastric cannula. 10 
minutes after incubation with charcoal mix, guinea pigs were 
sacrificed to evaluate the charcoal migration. The effect of 
CRF treatment on lower GI transit was measured by fecal pellet 
output (FPO) assay in non-fasted guinea pigs. r/h CRF pep-
tides of different concentrations (1, 3, and 10 μg/kg) and vehi-
cle were injected IP in guinea pigs. Guinea pigs were IP inject-
ed with different concentrations of astressin (1, 3, and 10 μg/
kg), and after 15 minutes of stabilization, 10 μg/kg of CRF was 
injected IP in each group. Each guinea pig was incubated into 
an individual experimental cage, and cumulative number and 
weight of fecal pellets expelled were measured and recorded 
for 3 hours. WAS was performed as described by Bonaz and 
Taché14 and Miwa, et al.27 Stress model guinea pigs were accli-
matized on the platform in a box 1 hour daily for 3 days, and on 
the next 2 days, were given WAS. Sham stressed group was ac-
climatized on the platform for 1 hour daily for 5 days. A control 
group was not subjected to any kind of stress and kept in hous-
ing cages only. After WAS exposure for 1 hour on day 5, guinea 
pigs were administered charcoal mix, incubated for 15 minutes, 
and then sacrificed and evaluated for upper GI transit. Lower 
GI transit in stress model was measured by cumulative fecal 
pellets in the course of the 4th and 5th days of WAS. Statistical 
analysis was performed using repeated measures ANOVA with 
post hoc comparison. In all tests, statistical significance was as-
signed at p<0.05. All data were analyzed using SPSS software, 
version 12.0 for Windows (SPSS Inc., Chicago, IL, USA).
The effect of different doses (1, 3, and 10 μg/kg) of CRF pep-
tide was tested in upper GI transit by charcoal transit assay. As 
shown in Fig. 1, the percent (%) charcoal migration (cm) in 
control group (55.6±19.9) was relatively similar to that of CRF 
1 μg/kg (64.1±9.2) and 3 μg/kg (57.9±22.7) groups. However, 
IP CRF 10 μg/kg injected guinea pigs showed significant inhi-
bition of upper GI transit, compared to control (6.4±2.2 vs. 55.6± 
19.9) (Fig. 1). Similarly, the effect of different doses of CRF 
Fig. 1. The effect of different doses of CRF peptide on upper GI transit in 
guinea pig. Values are mean±SEM. *p<0.05 in comparison to control. 
CRF, corticotropin releasing factor; GI, gastrointestinal.
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peptide on lower GI transit was analyzed by FPO assay. As 
shown in Fig. 2A, the number of fecal pellets expelled in the 
control group was 7.8±4.4, whereas those in the CRF (1, 3, and 
10 μg/kg) IP injected groups were 9.8±4.5, 19.6±1.8, and 22.1± 
13.8, respectively. The data clearly showed a dose dependent 
increase in the FPO in CRF injected guinea pigs. As compared 
to controls, CRF 3 and 10 μg/kg treated guinea pigs significantly 
increased the cumulative fecal pellets and weight (Fig. 2). Up-
per and lower GI transit experiments in this study confirmed 
10 μg/kg of IP CRF was the most effective dose that can impact 
both upper and lower GI transit in the experimental model of 
guinea pig. Next, the effect of astressin was tested on this mod-
el. As shown in Fig. 3, pretreated guinea pigs with different 
doses (1, 3, and 10 μg/kg) of astressin significantly increases 
the upper GI transit, compared to only CRF 10 μg/kg treated 
model. In contrast, the effects of different doses (1, 3, and 10 
μg/kg) of astressin on lower GI transit significantly reduced 
FPO, compared to only the CRF 10 μg/kg treated model (Fig. 
4). WAS experiment was divided into three different groups: 
control, sham stress, and stress model. Charcoal migration as-
say showed that WAS had an insignificant effect on upper GI 
transit among different groups (Fig. 5). In contrast, WAS sig-
nificantly accelerated lower GI transit (Fig. 6). The cumulative 
FPO of the stress model was more than 3 fold compared to 
sham stress and control groups (p<0.05) (Fig. 6).
Several studies demonstrated that patients with one of the GI 
diseases often suffer from a second overlapping disease.29-32 A 
recent population based study from China based on Rome III 
criteria showed 33% overlap of patients of IBS in FD patients and 
45.9% of FD in IBS patients.30 Again a study from Japanese gen-
eral population showed the prevalence of overlap of FD and/or 
IBS in gastroesophageal reflux disease (GERD), GERD, and/or 
IBS in FD, and GERD and/or FD in IBS were 46.9, 47.6, and 
34.4% respectively.2 Apart from high prevalence, our previous 
study, as well as several other reports, have suggested a health 
related decline in quality of life and higher severity symptom 
score among patients of FD-IBS overlap.2,29-33 Despite higher in-
cidence, there is no successful animal model with face and con-
struct validity for human syndrome. Therefore, it was imperative 
to develop an animal model that could mimic more than one 
symptom of the human overlap syndrome and could be used 
for the identification of molecular targets in drug development.
Fig. 2. Effect of different doses of CRF peptide on the lower GI transit in guinea pig. (A) The effect of different concentrations of CRF on the number of 
cumulative fecal pellets. (B) The effect of different concentrations of CRF on the cumulative FPO weight (g). Values are mean±SEM. *p<0.05, †p<0.01 
in comparison to control. CRF, corticotropin releasing factor; GI, gastrointestinal; FPO, fecal pellet output.
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Fig. 3. The effect of astressin on upper GI transit in comparison to only 
CRF 10 μg/kg. Values are mean±SEM. *p<0.01, †p<0.001. CRF, cortico-
tropin releasing factor; GI, gastrointestinal.
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Emerging evidence links the activation of CRF receptors with 
stress-related alterations of gastric and colonic motor func-
tion.34-37 In order to establish an experimental animal model of 
overlap syndrome, the present study targeted CRF receptors to 
analyze its effects on upper and lower GI transit in conscious 
guinea pigs. This study showed that 10 μg/kg IP CRF signifi-
cantly inhibited upper GI transit, compared to controls. In con-
trast, IP CRF led to dose dependent acceleration of lower GI 
transit, compared to controls. Therefore, our data clearly indi-
cated that peripheral administration of CRF simultaneously ex-
erts an inhibitory effect on upper gastric transit and stimulatory 
effect on colonic propulsive activity. Our findings support earli-
er observations that central or peripheral CRF suppresses gas-
tric emptying and stimulates colonic transit.24-26,34-37
To validate whether CRF indeed alters gastric and colonic 
transits through modulation of peripheral CRF receptors, dif-
ferent doses of CRF receptor antagonist astressin were injected 
IP in conscious guinea pigs. Our data showed that even the 
lowest dose (1 μg/kg) of astressin significantly blocks exoge-
nous CRF-induced alterations of gastric and colonic transits. 
Hence, our study confirms that CRF acts through peripheral 
CRF pathways and corroborated earlier findings indicating the 
differential role of non-selective CRF peptide on the gastric 
emptying and colonic transit.34-37 Several studies demonstrated 
Fig. 5. The effect of water avoidance stress on upper GI charcoal transit 
(%) in guinea pigs. Values are mean±SEM. NS, not significant; GI, gas-
trointestinal.
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Fig. 6. Effect of water avoidance stress (WAS) on lower GI transit in 
guinea pigs. The number of cumulative fecal pellets in control, sham 
stress and stress groups due to WAS. Values are mean±SEM. *p<0.01, 
†p<0.05 is significant. GI, gastrointestinal; FPO, fecal pellet output; NS, 
not significant.
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Fig. 4. The effect of astressin on (A) the number of cumulative fecal pellets and (B) cumulative fecal weight in comparison to only CRF 10 μg/kg. 
Mean±SEM (n=6/group). *p<0.01. CRF, corticotropin releasing factor; FPO, fecal pellet output.
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the selective CRF action on the activation of CRF2 receptors in 
the inhibition of gastric emptying and CRF1 receptors in the 
stimulation of colonic transit.34,38,39 Thus, these results strongly 
suggest that CRF receptor subtypes 2 and 1 may be activated si-
multaneously during stress or during central and peripheral 
administration of CRF.34-37
The WAS model was applied to analyze the role of central CRF 
pathways in GI motility. The WAS model represents psychologi-
cal stress condition in guinea pigs.27 Our study clearly showed an 
increase in cumulative FPO in stress model, compare to sham 
stress and control groups. This corroborates earlier findings that 
WAS stimulates colonic motility mediated by the central CRF 
pathway.14,27,28,40 Surprisingly, there was an insignificant differ-
ence in upper GI transit among the control, sham stress, and 
stress models. This is in contrast to earlier findings that indicated 
delayed gastric emptying due to WAS.28 We speculate that acute 
WAS may fail to produce a certain high threshold level of CRF to 
modulate the upper GI motility. Our peripheral CRF data (Fig. 1) 
precisely indicated high dose (10 μg/kg) and inhibition of upper 
GI transit. In addition to vital threshold dose, the distribution of 
CRF receptor subtypes (1 and 2) may induce opposite actions 
on upper and lower GI transit.25,34
In conclusion, peripheral r/h CRF was found to induce op-
posite actions on upper and lower gut transit in conscious 
guinea pigs. WAS involved central CRF signaling pathway stim-
ulated colonic propulsive activity, but failed to inhibit upper GI 
transit. CRF peptides were shown to mediate through interac-
tions with peripheral CRF receptors that have physiologic rele-
vance in acute psychological stress-induced overlap syndrome. 
This overlap syndrome model may provide new venues and 
construct validity for the identification of molecular targets/
biomarkers under stress-related activation of CRF pathways.
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